MODERN HEMATOLOGY SECOND EDITION
|
|
|
- Alannah Cain
- 9 years ago
- Views:
Transcription
1 MODERN HEMATOLOGY SECOND EDITION
2 CONTEMPORARY HEMATOLOGY Gary J. Schiller, MD, SERIES EDITOR Modern Hematology: Biology and Clinical Management, Second Edition, edited by REINHOLD MUNKER, ERHARD HILLER, JONATHAN GLASS, AND RONALD PAQUETTE, 2007 Stem Cell Transplantation for Hematologic Malignancies, edited by ROBERT J. SOIFFER, 2004 Biologic Therapy of Leukemia, edited by MATT KALAYCIO, 2003 Chronic Lymphocytic Leukemia: Molecular Genetics, Biology, Diagnosis, and Management, by GUY B. FAGUET, 2003 Modern Hematology: Biology and Clinical Management, by REINHOLD MUNKER, ERHARD HILLER, AND RONALD PAQUETTE, 2000 Red Cell Transfusion: A Practical Guide, edited by MARION E. REID AND SANDRA J. NANCE, 1998
3 MODERN HEMATOLOGY Biology and Clinical Management, Second Edition Edited by REINHOLD MUNKER, MD Louisiana State University, Shreveport, LA ERHARD HILLER, MD Ludwigs-Maximilians Universität, Munich, Germany JONATHAN GLASS, MD Feist Weiller Cancer Center, Louisiana State University, Shreveport, LA RONALD PAQUETTE, MD University of California Los Angeles, Los Angeles, CA Foreword by H. PHILLIP KOEFFLER, MD Cedars-Sinai Medical Center, Los Angeles, CA
4 2007 Humana Press Inc. 999 Riverview Drive, Suite 208 Totowa, New Jersey humanapress.com For additional copies, pricing for bulk purchases, and/or information about other Humana titles, contact Humana at the above address or at any of the following numbers: Tel: ; Fax: ; website at humanapress.com All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise without written permission from the Publisher. All articles, comments, opinions, conclusions, or recommendations are those of the author(s), and do not necessarily reflect the views of the publisher. Due diligence has been taken by the publishers, editors, and authors of this book to ensure the accuracy of the information published and to describe generally accepted practices. The contributors herein have carefully checked to ensure that the drug selections and dosages set forth in this text are accurate in accord with the standards accepted at the time of publication. Notwithstanding, as new research, changes in government regulations, and knowledge from clinical experience relating to drug therapy and drug reactions constantly occurs, the reader is advised to check the product information provided by the manufacturer of each drug for any change in dosages or for additional warnings and contraindications. This is of utmost importance when the recommended drug herein is a new or infrequently used drug. It is the responsibility of the health care provider to ascertain the Food and Drug Administration status of each drug or device used in their clinical practice. The publisher, editors, and authors are not responsible for errors or omissions or for any consequences from the application of the information presented in this book and make no warranty, express or implied, with respect to the contents in this publication. This publication is printed on acid-free paper. ANSI Z (American National Standards Institute) Permanence of Paper for Printed Library Materials. Production Editor: Tracy Catanese Cover Illustration: Figure 3 from Chapter 9, Acute Myelogenous Leukemias by. Cover design by Patricia F. Cleary. Authorization to photocopy items for internal or personal use, or the internal or personal use of specific clients, is granted by Humana Press Inc., provided that the base fee of US $30.00 per copy is paid directly to the Copyright Clearance Center at 222 Rosewood Drive, Danvers, MA For those organizations that have been granted a photocopy license from the CCC, a separate system of payment has been arranged and is acceptable to Humana Press Inc. The fee code for users of the Transactional Reporting Service is: [ /07 $30.00]. Printed in the United States of America e-isbn-13: e-isbn-10: Library of Congress Cataloging-in-Publication Data Modern hematology : biology and clinical management / edited by... [et al.]. -- 2nd ed. p. ; cm. -- (Contemporary hematology) Rev. ed. of: Modern hematology /, Erhard Hiller, Ronald Paquette. c2000. Includes bibliographical references and index. ISBN-13: (alk. paper); ISBN-10: (alk. paper) 1. Blood--Diseases. 2. Hematology. I. Munker, Reinhold. II. Munker, Reinhold. Modern hematology. III. Series. [DNLM: 1. Hematologic Diseases. 2. Hematologic Neoplasms. WH 120 M ] RC633.M '5--dc
5 FOREWORD Technological advances have quickly propelled hematology forward; for example: microarray expression analyses; single-nucleotide polymorphism (SNP) chips (platforms to look at genomic changes); sophisticated fluorescent in situ hybridization; newly identified cell surface antigens associated with various diseases and cell types; understanding of transcription factors (engines of proliferation and differentiation of hematopoietic cells); and more complete knowledge of chromosomal changes, mutations and amplifications associated with various hematological malignancies. These advances have been the engines for better diagnosis and classification of hematopoietic disorders. Furthermore, a variety of new therapeutic approaches have come to the forefront, such as targeted therapies (thyrosine kinase inhibitors) for myeloproliferative disorders; lenalidomide for myelodysplastic syndrome (MDS) and multiple myeloma; demethylating agents for MDS and myeloid leukemia, as well as, humanized monoclonal antibodies for lymphomas. Many of these advancements have occurred since the first edition of Modern Hematology: Biology and Clinical Management by Dr. Rienhold Munker and colleagues was published 6 years ago. This new edition, edited by Drs., Erhard Hiller, Jonathan Glass, and Ronald Paquette, provides in clear terms an understanding of the cellular physiology, immunology, and molecular biology of hematopoietic disorders. It gives new diagnostic methodologies and guides the health care worker to practical approaches to the diagnoses and management of these blood disorders. The book covers all of the major hematopoietic diseases and a number of the rare diseases as they interface with new scientific knowledge. It has excellent how to tables providing dosage and time schedules of different chemotherapeutic agents, as well as clearly defined tables to aid in diagnosis and prognosis. Modern Hematology: Biology and Clinical Management, Second Edition is a fine montage of applied research and practical approaches to diagnosis and management of our patients. The book is ideal for the house officers, fellows in training, interested scientists, as well as the practicing hematologist. H. Phillip Koeffler, MD v
6 PREFACE In the 6 years since the publication of Modern Hematology: Biology and Clinical Management, major advances in the understanding, diagnosis, and treatment of blood disorders have again been made. Molecular studies are now used on a daily basis to diagnose a variety of hematological disorders and to guide their treatment. Targeted therapies, such as kinase inhibitors in myeloproliferative disorders and humanized monoclonal antibodies for lymphomas, have transformed the treatment approach to these diseases. Peripheral blood and even umbilical cord blood are now routinely used as sources of stem cells for transplantation. The growing use of nonmyeloablative transplantation emphasizes immunotherapy over cytotoxic chemotherapy. These advances motivated us to update Modern Hematology: Biology and Clinical Management with the latest clinical and scientific developments in hematology. We welcome the contributions of new authors. The growing use of databases prompted us to add an overview of printed and electronic resources for hematologists. Modern Hematology: Biology and Clinical Management, Second Edition brings together facts, concepts, and protocols important for the practice of hematology. In 23 concise chapters, all major blood diseases are covered; rarer diseases are discussed if they are of scientific interest. The first two chapters introduce the reader to the scientific basis of blood disorders. As in the previous edition, each chapter is illustrated by tables, figures, and a selection of color plates. Our text is ideal for residents or fellows in training. However, students, physicians in other specialties, and even pure scientists may take advantage of our book both as a reference and a study guide. We hope that ultimately, all patients with benign and malignant blood disorders will benefit from the publication of Modern Hematology: Biology and Clinical Management, Second Edition., MD Erhard Hiller, MD Jonathan Glass, MD Ronald Paquette, MD vii
7 CONTENTS Foreword... v Preface... vii Contributors...xi Color Plates... xiii 1 Basic Biology of Hemopoiesis Molecular Biology and Cytokines and Amanda Sun 3 Supportive Care in Hematology John Hiemenz and 4 Transplantation of Stem Cells From Bone Marrow, Peripheral Blood, and the Umbilical Cord Ronald Paquette and 5 Anemias: General Considerations and Microcytic, and Megaloblastic Anemias Hemolytic Anemias...101, Ali Mansouri, Snehalata C. Gupte, and Vishwas Sakhalkar 7 Leukocytosis, Leukopenia, and Other Reactive Changes of Myelopoiesis The Myeloproliferative Syndromes Ronald Paquette, Erhard Hiller, and 9 Acute Myelogenous Leukemias Acute Lymphoblastic Leukemias and Vishwas Sakhalkar 11 Myelodysplastic Syndromes Ronald Paquette and 12 Aplastic Anemias Ronald Paquette and ix
8 x Contents 13 Lymphocytosis, Lymphocytopenia, Lymphadenopathy, and Splenomegaly Hodgkin s Lymphoma Erhard Hiller and 15 The Non-Hodgkin s Lymphomas...237, Jay Marion, Gang Ye, and Martin H. Dreyling 16 Multiple Myeloma and Related Paraproteinemias Jonathan Glass and 17 Congenital and Acquired Immunodeficiencies Vishwas Sakhalkar and 18 Infections Relevant to Hematology Basic Principles of Hemostasis Erhard Hiller 20 Bleeding Disorders Erhard Hiller 21 Thrombophilia, Thromboembolic Disease, and Antithrombotic Therapy Erhard Hiller 22 Transfusion Medicine and Immunohematology Grace C. Tenorio, Snehalata C. Gupte, and 23 Storage Disorders in Hematology APPENDICES 1 Glossary of Cytostatic Drugs and Targeted Therapies CD Nomenclature for Human Leukocyte Antigens Laboratory Values Program Requirements for Residency and Fellowship Education in Hematology Databases in Hematology Index...475
9 CONTRIBUTORS MICHAEL COCKERHAM, PharmD Associate Professor of Clinical Pharmacy, Louisiana State University, Shreveport, LA MARTIN H. DREYLING, MD Associate Professor of Medicine, Ludwigs- Maximilians Universität, Munich, Germany JONATHAN GLASS, MD Professor of Medicine and Chief, Feist Weiller Cancer Center, Louisiana State University, Shreveport, LA SNEHALATA C. GUPTE, PhD Director, Surat Blood Transfusion Center, Surat, India JOHN HIEMENZ, MD Professor of Medicine, Louisiana State University, Shreveport, LA ERHARD HILLER, MD Professor of Medicine, Ludwigs-Maximilians Universität, Munich, Germany H. PHILLIP KOEFFLER, MD Division of Hematology/Oncology, Cedars Sinai Medical Center, Los Angeles, CA ALI MANSOURI, MD Professor of Medicine, Louisiana State University and Chief, Division of Hematology/Oncology, VA Medical Center, Shreveport, LA JAY MARION, MD Associate Professor of Medicine, Louisiana State University, Shreveport, LA REINHOLD MUNKER, MD Associate Professor of Medicine, Louisiana State University, Shreveport, LA RONALD PAQUETTE, MD Associate Professor of Medicine, University of California Los Angeles, Los Angeles, CA VISHWAS SAKHALKAR, MD Assistant Professor of Pediatrics, Louisiana State University, Shreveport, LA AMANDA SUN, MD, PhD Assistant Professor of Medicine, Louisiana State University, Shreveport, LA GRACE C. TENORIO, MD Assistant Professor of Pathology, Louisiana State University, Shreveport, LA GANG YE, MD Louisiana State University, Shreveport, LA xi
10 COLOR PLATES Color plates 1 23 appear in an insert following p Plate 1 Fig. 5.2, Megaloblastic Erythroblasts; for full caption, see p. 94. Plate 2 Fig. 7.1, Granulocytes; for full caption, see p Plate 3 Fig. 7.2, Döhle Bodies; for full caption, see p Plate 4 Fig. 9.3, APL, Myeloid Blasts; for full caption, see p Plate 5 Fig. 9.4, Peroxidase Stain, AML Blasts; for full caption, see p Plate 6 Fig. 9.5, Fluorescent in situ Hybridization in APL; for full caption, see p Plate 7 Fig. 10.2, ALL Lymphoblast; for full caption, see p Plate 8 Fig. 10.3, Blasts of B-ALL; for full caption, see p Plate 9 Fig. 11.1, Dysplastic Changes in Erythropoiesis; for full caption, see p Plate 10 Fig. 11.2, Ringed Sideroblasts, MDS; for full caption, see p Plate 11 Fig. 12.1, Aplastic Anemia, Histology; for full caption, see p Plate 12 Fig. 12.2, Normal Bone Marrow, Histology; for full caption, see p Plate 13 Fig. 13.3, Howell Jolly Bodies; for full caption, see p Plate 14 Fig. 14.2, Lymph Node, Hodgkin s; for full caption, see p Plate 15 Fig. 15.1, Lymph Node, Non-Hodgkin s; for full caption, see p Plate 16 Fig. 15.2, Follicle Center Lymphoma; for full caption, see p Plate 17 Fig. 15.3, CLL Morphology; for full caption, see p Plate 18 Fig. 15.4, PLL Morphology; for full caption, see p Plate 19 Fig. 15.5, Adult T-Cell Leukemia, Lymphoma; for full caption, see p Plate 20 Fig. 15.6, Hairy Cell Leukemia; for full caption, see p Plate 21 Fig. 16.2, Multiple Myeloma, Dense Infiltrate of Neoplastic Plasma Cells; for full caption, see p Plate 22 Fig. 16.3, Multiple Myeloma, Bone Marrow; for full caption, see p Plate 23 Fig. 18.1, Infectious Mononucleosis; for full caption, see p xiii
Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014
ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the
Introduction. About 10,500 new cases of acute myelogenous leukemia are diagnosed each
Introduction 1.1 Introduction: About 10,500 new cases of acute myelogenous leukemia are diagnosed each year in the United States (Hope et al., 2003). Acute myelogenous leukemia has several names, including
LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons
LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:
A Career in Pediatric Hematology-Oncology? Think About It...
A Career in Pediatric Hematology-Oncology? Think About It... What does a pediatric hematologist-oncologist do? What kind of training is necessary? Is there a future need for specialists in this area? T
Malignant Lymphomas and Plasma Cell Myeloma
Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations
Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2
Adult Medical-Surgical Nursing H A E M A T O L O G Y M O D U L E : L E U K A E M I A 2 Leukaemia: Description A group of malignant disorders affecting: White blood cells (lymphocytes or leucocytes) Bone
Leukemias and Lymphomas: A primer
Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes
Stem Cell Transplantation
Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance
BONE MARROW FAILURE DISEASE SYMPOSIUM SATURDAY SEPTEMBER 27, 2014 AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT
SATURDAY SEPTEMBER 27, 2014 THE HOTEL HERSHEY 100 Hotel Road, Hershey, PA 17033 BONE MARROW FAILURE DISEASE SYMPOSIUM AN UPDATE ON THE LATEST IN DIAGNOSIS AND TREATMENT A CONTINUING EDUCATION SERVICE OF
chronic leukemia lymphoma myeloma differentiated 14 September 1999 Pre- Transformed Ig Surface Surface Secreted Myeloma Major malignant counterpart
Disease Usual phenotype acute leukemia precursor chronic leukemia lymphoma myeloma differentiated Pre- B-cell B-cell Transformed B-cell Plasma cell Ig Surface Surface Secreted Major malignant counterpart
Corporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll
Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology
Specific Standards of Accreditation for Residency Programs in Pediatric Hematology/Oncology INTRODUCTION 2009 A university wishing to have an accredited program in Pediatric Hematology/Oncology must also
LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials
LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational
DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT
www.narayanahealth.org DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT About Narayana Health City Narayana Health, one of India's largest and the world's most economical healthcare service providers
Acute myeloid leukemia (AML)
Acute myeloid leukemia (AML) Adult acute myeloid leukemia (AML) is a type of cancer in which the bone marrow makes abnormal myeloblasts (a type of white blood cell), red blood cells, or platelets. Adult
Oncology Best Practice Documentation
Oncology Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: Solid Tumors Lymphomas Leukemias Myelodysplastic Syndrome Pathology Findings
Acute Myeloid Leukemia
Acute Myeloid Leukemia Introduction Leukemia is cancer of the white blood cells. The increased number of these cells leads to overcrowding of healthy blood cells. As a result, the healthy cells are not
MEDICAL COVERAGE POLICY
Important note Even though this policy may indicate that a particular service or supply is considered covered, this conclusion is not necessarily based upon the terms of your particular benefit plan. Each
Lauren Berger: Why is it so important for patients to get an accurate diagnosis of their blood cancer subtype?
Hello, I m Lauren Berger and I m the Senior Director of Patient Services Programs at The Leukemia & Lymphoma Society. I m pleased to welcome Dr. Rebecca Elstrom. Dr. Elstrom is an Assistant Professor in
Cord Blood Stem Cell Transplantation
LEUKEMIA LYMPHOMA MYELOMA FACTS Cord Blood Stem Cell Transplantation No. 2 in a series providing the latest information on blood cancers Highlights Umbilical cord blood, like bone marrow and peripheral
Acute myeloid leukaemia (AML) in children
1 61.02 Acute myeloid leukaemia (AML) in children AML can affect children of any age, and girls and boys are equally affected. Leukaemia Acute myeloid leukaemia (AML) FAB classification of AML Causes of
Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA
Interesting Case Review Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA History 63 y/o male with h/o CLL for 10 years Presents with worsening renal function and hypercalcemia
GRANIX (tbo-filgrastim)
RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil
Mayo Clinic College of Medicine Pharmacy Services. Rotation Summary
Mayo Clinic College of Medicine Pharmacy Services Rotation Summary Rotation Title: PGY-2 Pediatric Hematology-Oncology Rotation Length: 3-6 weeks Primary Preceptor Name: Amanda Kuper, PharmD, BPCS, Ron
4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and
Daiichi Sankyo to Acquire Ambit Biosciences
For Immediate Release Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please
Hematopoietic Stem Cell Transplantation. Imad A. Tabbara, M.D. Professor of Medicine
Hematopoietic Stem Cell Transplantation Imad A. Tabbara, M.D. Professor of Medicine Hematopoietic Stem Cells Harvested from blood, bone marrow, umbilical cord blood Positive selection of CD34 (+) cells
»medical programs and services. transfusion medicine fellowship program
»medical programs and services transfusion medicine fellowship program new york blood center transfusion medicine fellowship program» Experience at one of the largest nonprofit, community-based blood centers
2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders
UPDATE ECIL-4 2011 2011 Update on the ECIL-3 guidelines for EBV management in patients with leukemia and other hematological disorders Jan Styczynski, Hermann Einsele, Rafael de la Camara, Catherine Cordonnier,
Haematopoietic Chimerism Analysis after Allogeneic Stem Cell Transplantation
Haematopoietic Chimerism Analysis after Allogeneic Stem Cell Transplantation Dr Ros Ganderton, Ms Kate Parratt, Dr Debbie Richardson, Dr Kim Orchard and Dr Liz Hodges Departments of Molecular Pathology
The Treatment of Leukemia
The Treatment of Leukemia Guest Expert: Peter, MD Associate Professor of Hematology Director, Yale Cancer Center Leukemia Program www.wnpr.org www.yalecancercenter.org Hi, I am Bruce Barber and welcome
Cord blood Banking Transplant List for One USA Bank - StemCyte www.stemcyte.com/cordblood-banking-transplant-list
Cells4Life is the oldest and largest cord blood storage company in the UK. We are governed by some of the world's most stringent medical laws, and are currently the only stem cell storage company in the
Houston Cancer Institute
Houston Cancer Institute A personal path to healing Memorial-West Houston Katy Northwest Houston Southeast Houston Sugar Land Convenience for Patients State of the Art Therapies and Diagnosis Real Support
5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries
Careers in Haematology
Careers in Haematology A Guide for Medical Students and Junior Doctors Haematology is the medical speciality concerned with blood disorders. Your non-medical friends however will always think that you
ACUTE MYELOID LEUKEMIA (AML),
1 ACUTE MYELOID LEUKEMIA (AML), ALSO KNOWN AS ACUTE MYELOGENOUS LEUKEMIA WHAT IS CANCER? The body is made up of hundreds of millions of living cells. Normal body cells grow, divide, and die in an orderly
Hematology Morphology Critique
Survey Slide: History: 60-year-old female presenting with pneumonia Further Laboratory Data: Hgb : 90 g/l RBC : 2.92 10 12 /L Hct : 0.25 L/L MCV : 87 fl MCH : 30.8 pg MCHC : 355 g/l RDW : 17.7 % WBC :
STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA
STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA OVO CLINIC I 8000 BLVD DECARIE, MONTREAL QC H4P 2S4 I 514.798.2000 I OVOCLINIC.COM 2 a therapeutic revolution As the
»medical programs and services. transfusion medicine fellowship program
»medical programs and services transfusion medicine fellowship program new york blood center transfusion medicine fellowship program» Experience at one of the largest nonprofit, community-based blood centers
What we will discuss today
Umbilical cord blood banking It s Utility? Dr. Nita Radhakrishnan Pediatric Hematology Oncology Unit, Sir Ganga Ram Hospital, New Delhi What we will discuss today What are stem cells? What are the sources
Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD
Cord Blood Banking Scott N. Furlan, MD Ellen S.Plummer, MD Overview Background Biology of Stem Cell Transplant Opportunities i at Parkland Logistics of Banking Potential Barriers Indications for HCT Cancer
An overview of CLL care and treatment. Dr Dean Smith Haematology Consultant City Hospital Nottingham
An overview of CLL care and treatment Dr Dean Smith Haematology Consultant City Hospital Nottingham What is CLL? CLL (Chronic Lymphocytic Leukaemia) is a type of cancer in which the bone marrow makes too
PT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank
Cordblood Stem Cells and The Role of Cordblood Bank in Supporting Stem Cells Research Presentation Overview Company profile Haematopoietic stem cells in cordblood What we can do to help 1 2 PT CordLife
Blood & Marrow Transplant Glossary. Pediatric Blood and Marrow Transplant Program Patient Guide
Blood & Marrow Transplant Glossary Pediatric Blood and Marrow Transplant Program Patient Guide Glossary Absolute Neutrophil Count (ANC) -- Also called "absolute granulocyte count" amount of white blood
Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD
Stem Cell Transplantation and the Canadian First Nations Community Becky Luk (PTLS) Tanya Petraszko, MD Why is there a need for stem cells? Our Story Why are we engaging the First Nations, Metis and Inuit
Cord Blood: Research Progress and Future Promise
Cord Blood: Research Progress and Future Promise By Al Staropoli, AABB Contributing Writer Sue Fister found out she had leukemia when she was 50 years old. Doctors suggested a bone marrow transplant as
3 PART ONE: The Principles of Hematology 1 4 2 PART TWO: Erythrocytes 89 5
CONTENTS Preface iv PART ONE: The Principles of Hematology 1 1 Safety and Quality in the Hematology Laboratory................................. 1 An Overview of the Hematology Laboratory 1 The Study of
PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA PROGNOSIS IN ACUTE MYELOID LEUKEMIA
PROGNOSIS IN ACUTE LYMPHOBLASTIC LEUKEMIA UNFAVORABLE Advanced age High leukocyte count at diagnosis Presence of myeloid antigens Late achievement of CR Chromosomal abnormalities: t(9:22)(q34:q11) t(4;11)(q21;q23)
SWOG ONCOLOGY RESEARCH PROFESSIONAL (ORP) MANUAL VOLUME I RESPONSE ASSESSMENT LEUKEMIA CHAPTER 11A REVISED: OCTOBER 2015
LEUKEMIA Response in Acute Myeloid Leukemia (AML) Response criteria in Acute Myeloid Leukemia for SWOG protocols is based on the review article Diagnosis and management of acute myeloid leukemia in adults:
Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
House Resolution No. 37
california legislature regular session House Resolution No. Introduced by Assembly Member Hill August, House Resolution No. Relative to umbilical cord blood banking. WHEREAS, Since the first umbilical
INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance
A. Bernheim Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MyR is funded by the European Commission within its FP7 specific
Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.
Complete Blood Count CPT Code: CBC with Differential: 85025 CBC without Differential: 85027 Order Code: CBC with Differential: C915 Includes: White blood cell, Red blood cell, Hematocrit, Hemoglobin, MCV,
Corporate Medical Policy Genetic Testing for Fanconi Anemia
Corporate Medical Policy Genetic Testing for Fanconi Anemia File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_fanconi_anemia 03/2015 3/2016 3/2017 3/2016 Description
Program Co-Chairmen: Dr. John Wagner, University of Minnesota Dr. Richard Champlin, M.D. Anderson Cancer Center
(last updated May 13, 2004) This is an activity offered by CBBS, a CMA accredited provider. Physicians attending this course may report up to 13.25 hours of Category 1 credits toward the California Medical
What is a Stem Cell Transplantation?
What is a Stem Cell Transplantation? Guest Expert: Stuart, MD Associate Professor, Medical Oncology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with Drs. Ed and Ken. I am
Things You Don t Want to Miss in Multiple Myeloma
Things You Don t Want to Miss in Multiple Myeloma Sreenivasa Chandana, MD, PhD Attending Hematologist and Medical Oncologist West Michigan Cancer Center Assistant Professor, Western Michigan University
CHAPTER 2. Neoplasms (C00-D49) March 2014. 2014 MVP Health Care, Inc.
Neoplasms (C00-D49) March 2014 2014 MVP Health Care, Inc. CHAPTER SPECIFIC CATEGORY CODE BLOCKS C00-C14 Malignant neoplasms of lip, oral cavity and pharynx C15-C26 Malignant neoplasms of digestive organs
Corporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: adoptive_immunotherapy 11/1993 3/2016 3/2017 3/2016 Description of Procedure or Service The spontaneous regression
What is chronic lymphocytic leukaemia?
Revised October 2011 What is chronic lymphocytic leukaemia? The diagnosis of a blood cancer can be a devastating event for patients, families and friends. It is therefore vital for everyone to have access
Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center
Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center Bodnar s Law Simple Things are Important Very Simple Things are Very Important
Blood and Marrow Stem Cell Transplantation
Blood and Marrow Stem Cell Transplantation Revised 2013 A Message from Louis J. DeGennaro, PhD President and CEO of The Leukemia & Lymphoma Society The Leukemia & Lymphoma Society (LLS) is committed to
Clinical trials. Patient information. For anyone affected by blood cancer. bloodwise.org.uk
Clinical trials For anyone affected by blood cancer bloodwise.org.uk Patient information A note about this booklet This booklet has been produced by Bloodwise, the new name for Leukaemia & Lymphoma Research.
ST. VINCENT'S. MEDICAL CENTER St. Vincent's Healthcare
ST. VINCENT'S MEDICAL CENTER St. Vincent's Healthcare Medical Technology St. Vincent s Schools of Medical Science Throughout Northeast Florida and Southern Georgia, St. Vincent s HealthCare is well known
March 19, 2014. Dear Dr. Duvall, Dr. Hambrick, and Ms. Smith,
Dr. Daniel Duvall, Medical Officer Center for Medicare, Hospital and Ambulatory Policy Group Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, Maryland 21244 Dr. Edith Hambrick,
Exercise 9: Blood. Readings: Silverthorn 5 th ed, 547 558, 804 805; 6 th ed, 545 557, 825 826.
Exercise 9: Blood Readings: Silverthorn 5 th ed, 547 558, 804 805; 6 th ed, 545 557, 825 826. Blood Typing The membranes of human red blood cells (RBCs) contain a variety of cell surface proteins called
From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes
ISSN 2154-4006 The Genetic Basis of Human Disease zbar Colloquium series on Series Editor: Michael Dean, Ph.D., Head, Human Genetics Section, Senior Investigator, Laboratory of Experimental Immunology
BCSLS Telehealth Stem Cell Transplantation. Becky Luk, Patient & Transplant Liaison Specialist
BCSLS Telehealth Stem Cell Transplantation Becky Luk, Patient & Transplant Liaison Specialist Our Story Why is there a need for stem cells? What is OneMatch Stem Cell & Marrow Newtork s role in Stem Cell
guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research
infoaging guides BIOLOGY OF AGING STEM CELLS An introduction to aging science brought to you by the American Federation for Aging Research WHAT ARE STEM CELLS? Stem cells are cells that, in cell cultures
Phone: +44 20 8123 2220 Fax: +44 207 900 3970 [email protected] http://marketpublishers.com
Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012-2020
Not All Stem Cells are the Same
Cord Blood Banking and Transplantation Jennifer Willert, M.D. Hematology/Oncology Blood and Marrow Transplant Rady Children s Hospital San Diego Clinical Professor UCSD Not All Stem Cells are the Same
SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR.
SECOND PRIMARY BREAST CANCERS FOLLOWING HAEMATOLOGIC MALIGNANCIES A CASE SERIES STUDY FARAH TANVEER PGY 3 DR.MEIR WETZLER DR. TRACEY O CONNOR RESEARCH QUESTON Patients with previously diagnosed hematologic
cord blood saves lives...
cord blood saves lives... ...by providing a rich source of blood stem cells that can be used to treat over 80 different diseases including leukemia, lymphoma, thalassemia, Tay-Sachs and sickle cell anemia.
The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant
The Infinite Potential of Stem Cell Japan s Cord Blood Bank and Transplant Speech by Dr. Tsuneo A. Takahashi Translated by Stella Wang Japan and the United States are the two most experienced countries
Dr. Vivian Pijuan-Thompson (Cytology) http://www.uab.edu/cds/academic/graduate/ct (Cytology)
Clinical Laboratory Sciences (M.S.) Degree Offered: M.S. Directors: Dr. Janelle Chiasera, interim (CLS) Dr. Vivian Pijuan-Thompson (Cytology) Phone: (205) 975-3111 (Chiasera) (205) 934-3378 (Pijuan-Thompson)
AREAS EMPLOYERS STRATEGIES/INFORMATION PHYSICAL THERAPY
HEALTHCARE SCIENCES Physical & Occupational Therapy, Cytotechnology, Dental Hygiene, Health Information Management, Clinical Laboratory Science What can I do with these degrees? PHYSICAL THERAPY Physical
My Sister s s Keeper. Science Background Talk
My Sister s s Keeper Science Background Talk Outline Acute promyelocytic leukemia (APL) APL Treatment Savior Siblings In vitro fertilization (IVF) Pre-implantation Genetic Diagnosis (PGD) Risks of donating
CAP Accreditation Checklists 2015 Edition
CAP Accreditation Checklists 2015 Edition The College of American Pathologists (CAP) accreditation checklists contain the CAP accreditation program requirements, developed on more than 50 years of insight
Cancer. 9p21.3 deletion. t(12;21) t(15;17)
CANCER FISH PROBES INDIVIDUAL AND PANEL S Acute Lymphoblastic Leukemia (ALL) ALL FISH Panel (includes all probes below) 8010 LSI MYB/CEP6 LSI p16 (CDKN2A) LSI BCR/ABL with ASS LSI ETV6 (TEL)/AML1 (RUNX1)
Multiple Myeloma. This reference summary will help you understand multiple myeloma and its treatment options.
Multiple Myeloma Introduction Multiple myeloma is a type of cancer that affects white blood cells. Each year, thousands of people find out that they have multiple myeloma. This reference summary will help
This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking
Q1/2016 This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking statements involve risks and uncertainties
Interesting Case Series. Periorbital Richter Syndrome
Interesting Case Series Periorbital Richter Syndrome MarkGorman,MRCS,MSc, a Julia Ruston, MRCS, b and Sarath Vennam, BMBS a a Division of Plastic Surgery, Royal Devon and Exeter Hospital, Exeter, Devon,
Chapter 4 Section 23.1. High Dose Chemotherapy (HDC) And Stem Cell Transplantation
Surgery Chapter 4 Section 23.1 High Dose Chemotherapy (HDC) And Stem Cell Transplantation Issue Date: November 1, 1983 Authority: 32 CFR 199.4(e)(5) and (g)(15) 1.0 CPT 1 PROCEDURE CODES 38205, 38207,
Summary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status
of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Shelley Grant Branch Chief, Blood Stem Cell Transplantation Program September 11, 2015 Overview December 20, 2005 - HRSA began
MANAGEMENT OF DATA IN CLINICAL TRIALS
MANAGEMENT OF DATA IN CLINICAL TRIALS Second Edition ELEANOR MCFADDEN Frontier Science, Ltd. Kincraig, Inverness-shire, Scotland WILEY-INTERSCIENCE A JOHN WILEY & SONS, INC., PUBLICATION MANAGEMENT OF
